Biomarkers in Nonalcoholic Fatty Liver Disease

Neuman Manuela G; Cohen Lawrence B; Nanau Radu M

首页> 外文期刊>ISRN Hypertension >Biomarkers in Nonalcoholic Fatty Liver Disease

【24h】

Biomarkers in Nonalcoholic Fatty Liver Disease

机译：非酒精性脂肪肝疾病中的生物标志物

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND Nonalcoholic fatty liver disease (NAFLD) is a chronic liver condition characterized by insulin resistance, type 2 diabetes and fat accumulation in the liver that may cause hepatic inflammation and progressive scarring leading to nonalcoholic steatohepatitis (NASH) and irreversible liver damage (cirrhosis). As a result, there has been increased recognition of the need to assess and closely monitor individuals for risk factors of components of NAFLD and NASH, as well as the severity of these conditions using biomarkers.

机译：背景技术非酒精性脂肪肝疾病（NAFLD）是一种慢性肝脏疾病，其特征在于胰岛素抵抗，2型糖尿病和肝脏中的脂肪积聚，可能引起肝炎和进行性瘢痕形成，从而导致非酒精性脂肪性肝炎（NASH）和不可逆的肝损害（肝硬化）。结果，人们越来越认识到需要评估和密切监测个体的NAFLD和NASH成分的危险因素，以及使用生物标记物对这些疾病的严重性。

著录项

来源
《ISRN Hypertension》 |2014年第11期|共12页
作者
Neuman Manuela G; Cohen Lawrence B; Nanau Radu M;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词

相似文献

外文文献
中文文献
专利

1. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. [J] . Malik R, Chang M, Bhaskar K, Journal of gastroenterology and hepatology . 2009,第4期

机译：生物标志物和非酒精性脂肪性肝炎CRN肝活检评分系统在非酒精性脂肪肝患者中的临床应用。
2. Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis [J] . Cyrielle Caussy, Lars Johansson Endocrinology, Diabetes & Metabolism . 2020,第4期

机译：基于磁共振的非酒精性脂肪肝疾病和非酒精性脂肪肝炎的生物标志物
3. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography [J] . Eugenia Tsai, Tai-Ping Lee Clinics in liver disease . 2018,第1期

机译：非酒精性脂肪肝疾病/非酒精脂肪肝炎的诊断和评价，包括非血清生物标志物和瞬态弹性术
4. A Global LC-MS Metabolomics Approach for Biomarker Identification in Patients with Nonalcoholic Fatty Liver Disease [C] . Rainey E. Patterson, M. Romina Lomonaco, Nishanth E. Sunny, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：非酒精性脂肪肝病患者生物标志物鉴定的全球LC-MS代谢组合方法
5. Relationships between hyperleptinemia, hyperinsulinemia, hypertriglyceridemia and elevations in markers of liver disease for nonalcoholic fatty liver disease in Hispanic children. [D] . Patel, Bhavin. 2003

机译：高脂蛋白血症，高胰岛素血症，高甘油三酯血症与西班牙裔儿童非酒精性脂肪肝疾病肝脏疾病标志物升高之间的关系。
6. Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis [O] . Cyrielle Caussy, Lars Johansson 2020

机译：基于磁共振的非酒精性脂肪肝疾病和非酒精性脂肪肝炎的生物标志物
7. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease [O] . Veeral Ajmera, Emily R. Perito, Nathan M. Bass, 2016

机译：具有非酒精性脂肪肝病的成人肝病严重程度相关的新型血浆生物标志物

Biomarkers in Nonalcoholic Fatty Liver Disease

摘要

著录项

相似文献

相关主题

期刊订阅